International Journal on Science and Technology

E-ISSN: 2229-7677   •   Impact Factor: 9.88

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 16 Issue 2 April-June 2025 Submit your research before last 3 days of June to publish your research paper in the issue of April-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 16 Issue 2
April-June 2025

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Role of Nanotechnology in Enhancing Therapeutic Efficacy and Pharmacokinetic Profiles for Dengue

Author(s) Mr. ABISESH MUTHUSAMY, Dr.VINAYAK MASTIHOLIMATH
Country India
Abstract Abstract
Dengue virus (DENV) infection remains one of the world’s most pervasive mosquito‐borne threats, with nearly 390 million infections annually and approximately 96 million clinically apparent cases¹. Despite this enormous burden, there are no approved antivirals with both potent efficacy and favorable pharmacokinetics. Nanotechnology‐based delivery systems have emerged as powerful platforms to overcome traditional drug‐delivery barriers—poor solubility, rapid degradation, off‐target toxicity—by modulating drug physicochemistry, enhancing bioavailability, enabling precise targeting, and providing controlled release. Here, we comprehensively review advances in lipid‐, polymer‐, and inorganic‐based nanocarriers for dengue therapy, focusing on eleven major classes: phytosomes, liposomes, cubosomes, niosomes, ethosomes, transfersomes, solid lipid nanoparticles, nanostructured lipid carriers, dendrimers, polymeric micelles, nanoemulsions, and nanocrystals. For each, we detail composition and preparation, physicochemical characterization, mechanisms of cellular uptake and endosomal escape, multimodal antiviral and immunomodulatory actions, and quantitative pharmacokinetic improvements—including extended circulation, sustained release, and lymphatic uptake. Preclinical efficacy in dengue models is summarized alongside immunotoxicity, biodistribution, and regulatory considerations. Finally, we outline future directions in personalized and theranostic nanomedicines tailored to patient‐specific viral and immunological profiles.
Keywords Dengue, nanocarriers, bioavailability, targeted delivery, pharmacokinetics,controlled release, phytosomes, liposomes, dendrimers
Field Medical / Pharmacy
Published In Volume 16, Issue 2, April-June 2025
Published On 2025-05-26
DOI https://doi.org/10.71097/IJSAT.v16.i2.5587
Short DOI https://doi.org/g9mvsh
View / Download PDF File

Share this


CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJSAT DOI prefix is
10.71097/IJSAT

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 15 Isu 4Cover Page Vol 15 Isu 3Cover Page Vol 15 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJSAT
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us Message on WhatsApp +91-9687-182-185 editor@ijsat.org